Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Once sign that the shorts have returned is when you start to see TTLLF trading. They will need an inexpensive derivative to protect their naked short position against significant surprise spikes in the shares. Just imagine, your shorting the stock and material news comes out just before the open and you have to buy back your position many dollar$ later. Or it gets halted during the day and when it opens, you have to scramble like a madman. It can wipe you out in a matter of seconds. Keep your eyes on the TTLLF for signs of shorting everyone!
At Honeycomb: Most retail traders who buy warrants, like myself, have no intention of converting to common stock. Instead, they surf the parabolic leveraged price momentum with a fraction of the capital required to buy the shares. The end game, conversion targets are left to the big funds who exercise and convert their warrants into shares.
On the positive side, NO VOLUME on TTLLF means shorters are not hedging their bets just yet!
Not a single trade on TTLLF "I" warrants since the MDT announcement.
LIGHTROCK wrote:
So what ?
You don't want to just keep adding more people to your board every time the wind blows, you want the best ones for the tasks at hand.
The question I would ask, is will the new ones make the share price go up or down...
Beyond that, digging deeper, then "why" and "how"
I would hardly consider the MDT announcement a "by the way" passing moment. MDT is in a position of power to call all shots at TMD if they so decide to do so at the stroke of a pen and at the blink of a eye. Limiting their position to a board "observer" is interesting. Obviously TMD has something "value added" to be able to negotiate with the MDT giant as equals! A Napoleon moment, maybe.
MDT is limited to, only one "non-voting observer" to attend meetings of Titan's board of directors?? I don't see a conflict of interest in having one voting board member from MDT sit on TMD's board, does anyone else?? A voting board member doesn't control the board or the company. They simply have the ability to propose items to the agenda and vote on subject matters. When in a position of conflict, they simply are asked to abstain. This is setting the stage for something, doesn't make any sense to me.
I'm waiting for the other shoe to drop! Didn't anybody notice the MOST IMPORTANT element of the press release? Two directors are retiring (aka: giving their seats to someone else) from the board at the same time! TMD usually have their annual meeting docs out in the first two weeks in May, but this year have been delayed. The next shoe will drop when we see "WHO" will be listed on the next proxy. Will it be Execs from MDT?? Will it be a mix from another entity who could also sign a license deal?? Everyone is so focused on the money?! The real focus should be on the positioning for power which can only be obtained via a board seat or a controlling shareholder. The smart money should keep their eyes focused on the SEDAR (online company filing website) for this information to be published. Why would these directors want to retire now and not be part of what everyone has been waiting to happen for almost a decade!! The position of director is not that much work, nor does it require a significant portion of your time like would be the case of a top executive like a CEO, CFO, COO, etc.
Amazing, no pulse on TTLLF yet considering this parabolic rise on the underlying shares of TMDI.
Anyone playing the warrants Symbol: TTLLF ?
Why didn't MDT just buy them out!!?? Pocket change!! Hmm....
This is very positive news, I believe something significant happened in the last few days. These are all tactics some work & some don’t, consistent with forcing a material even to materialize. I always said that Karl Storz needs to have their logo on this platform. Could materialize into a significant spike very soon!
IMO, This is the final chapter when another company comes in to take it out for a token amount higher than the last ten days trading price. BOD and management will state; "we believe that this transaction provides the best liquidity opportunity for shareholders". Then go on to say; "Reaching this conclusion is an important step for the technology, as it will provide the expertise and the financial resources to best help the platform achieve its full potential. We look forward towards its successful completion."
The customary break up fee of $3+ million will no doubt apply to ensure the financial nail in the coffin scenario.
Formation of a special committee and fairness opinion will follow.
Shareholder approval of at least 66-2/3rds per cent of the votes cast by shareholders present in person or represented by proxy at the special meeting.
Just another Canadian company with promising medical technology being taken out to the back of the shed just before final commercial validation.
This is not a financing "hiccup" but rather something(s) material going on behind the scenes. Hope its NOT a buyout before human trials validation because it would be given away at a discount. Hostile versus plan of arrangement with lockup & break penalty?? Hopegully they are not stupid enough to agree to a plan of arrangement! A financing at these levels would be neutral. Best case scenario is a JV Partner. That would be the only avenue to a much higher share price.
This financing is simply a strategy to get the companies that are looking at TMD to “chit or get off the potty” in the homestretch. The financing structure is NOT consistent with a go it alone strategy, but rather one that lights a fire underneath. Simply brilliant!!
Specific Land Claim Settlement of $128 million Kanesatake!!
The OKA-Canada deposit has been on hold due to an outstanding aboriginal "specific" land claims negotiation for over a decade. Now that the $128million proposed settlement has been announced, that would free up all property in the claimed territory of the two mountains area, including of course the deposit. Specific land claims are settled by monetary compensation, not expropriation, and the compensation amount is designed to buy property on the open market, if the aboriginals wish to do so. The municipality of OKA will now be able to reap the royalty and economic benefits once the last permit is issued, being the CA (certificate of authorization) which allows you to go into commercial production, having received all previous permits required. Niobium is used mainly to strengthen structural steel, makes steel lighter in cars for less CO2 emissions, but also in electric car batteries for further distances on a single charge and medical CT scans, no name only a few. The company also owns the Great Whale Iron deposit in James Bay- Canada. This is a 100% magnetite billion ton resource with a content of 36%-41% Fe, right next to a deep water port and LG2 hydro electric generationg station. There are no NSR (net smelter) royalties on the property. The ideal location and a metal that will benefit from the trade tarriff war. I believe the company has the goods to benefit going forward.
At Sport19; he also mentioned during the 2019 annual meeting that transactions (recent acquisitions) for companies like TMD have been north of $1 billion! That says alot when they form the "special committee" of independent directors and the formal valuation(s) to refuse anything under $40/share. At that price, series G, H & I warrants are deep in the money!
Its already publicaly disclosed that HOYA Corporation is working on a surgical robot via EndoMaster. IMO, TMD and EndoMaster team may have joined R&D forces to develop SPORT, or EndoMaster has been dropped from HOYA.
https://www.marketscreener.com/HOYA-CORPORATION-6491345/news/HOYA-CORPORATION-HOYA-to-Invest-in-EndoMaster-a-Company-for-a-Robotic-assisted-Surgical-System-17199708/
EndoMaster link:
http://www.endomastermedical.com/
At Sport19; I agree with you 100%. There are only 2 end effectors that I know of in the entire market. There are not 100 ways to patent this support design. Either screw or click. Microline (disposable or re-usable) has a double threaded support. One that screws onto the push/pull rod, to activate the distal link mechanism (open/close) and the other that supports the end effector main body.
Access Surgical which makes a twist & click (re-usable), was once popular about 10+ years ago, but the majority of the ones used today are the fixed end effector, or conplete instrument. https://www.symmetrysurgical.com/en/product/specialty-laparoscopy/12-5383
At QuidWilson, they sold Pentax "camera" business but STILL own Pentax Medical/Surgical. Look it up on the HOYA corporation website. https://www.pentaxmedical.com/pentax/en/92/1/HOYA-Parent-Company
At Sport19; Pentax Medical is the scope supplier, just like I have always mentioned that Microline is the end effector. Both owned by the HOYA Corporation (HOAPF-q. The problem is, HOYA only has a market cap of 30$ billion U.S. that would make it too tiny to take out TMD for its REAL value as a standalone. It would however be possible that HOYA/TMD form a new JV-NEWCO and remain public. This has always been my original vision, but NOT the best fit to maximize value for the technology and the company. You need a sticker with some market recognition for it to blast off. Karl Storz would be the best fit, so maybe we might also see a 3 way JV-NEWCO merger. Question is, would the name on the platform be, SPORT by Pentax or SPORT by KARL STORZ??
KS and Stryker never manufactured any clips and only KS did make a clip applier but only a forcep to apply. For Stryker it has always been about orthopedics, and Laparoscopy has always been a sideshow, but for KS its their bread & butter.
At Sport19, whats bugging me is that Dr. Dennis Fowler is now a high level exec. with Karl Storz. Why was he hand picked amongst hundreds of possible M.I.S. specialists across the country? Wild coincidence, maybe, but my experience in this field has always been for a perfect fit with Karl Storz, either JV or buyout. Why in the world would the leading manual endoscopy manufacturer NOT be interested in participating in the "next generation" technology, or continue with what will result in them becoming obsolete?? At the very least, if your not willing to put in the time, effort and money to develop a robotic Platform, leverage your name onto a sticker label of one already developed.
At Sport19, GLG wrote "locked already. 125 million venture on the books".
Is that bull??
At glg20; could you or anyone please elaborate on this 125 million venture on the books? Any press release or mention of the company?
At pontiacg6: I only glance in here from time to time, but I definately missed this very important piece of information on Fowler. Chief Medical officer at Storz since Jan 2019! Obviously he is tied by confidentially & non-compete TMD contract due to his patent royalty agreement, but would be allowed under a TMD approved waver to consult for Storz if they were in JV or DD talks with TMD. I will need to look into this and consult ihub on a more regular basis going forward.
At glg20; pls elaborate, did I miss something?
Lots of talk of a buyout, but a JV could be even better and TMD kept public. I still believe that Karl Storz, worlds largest manual endoscopy manufacturer, will want to put their name on SPORT. I don't know if they have deep enough pockets to purchase TMD at this point due to it a being private, so they may want to be satisfied with a controlling position in a public entity. I still cannot believe that Storz has not yet started R&D robots or partnered with someone. After all the founder is also a founding board member of IHU Strasbourg!
Don’t undermine the management behind DTEA and CTU (Le Chateau) or LCUAF. This is NOT, by any meas, their first rodeo! This experience cannot be taught in school but the true winners are the ones that come out of it even stronger than their previous peak!! An innate quality. The retail trade has its ups and downs I don’t hold any DTEA but it might be of interest to some that their original CEO during the IPO joined the BOD of MJ (True Leaf Brands) one year ago as an independent director. Positioning? I bought a nice chunk of CTU (LCUAF)on the cheap recently for the specific reason of that management has been there and done that. Until they prove otherwise, I will bank on their experience to prove everyone wrong. Long & strong CTU (LCUAF)
Still lots of time to play ball with warrants from design freeze (sweet spot) going forward:
Series "F": 16-Nov-2020 (556 days to maturity)
Series "G": 17-Feb-2021 (647 days to maturity)
Series "H": 31-Mar-2021 (690 days to maturity)
Series "I": 20-Sep-2021 (860 days to maturity)
No need to do private placements anymore, exercise your way to financing!!
I like the ingenious design idea of the Medline, the problem is that they are complicated to properly assemble due to their dual screw on mecanism. The pushrod has a screw on thread to make the articulations links function and the outer head has another seperate thread assembly. It sometimes takes several attemps to made it function due to the dual thread. Many don't know if you assemble with the jaws open or closed, pushrod engaged or not. The second issue I have with them are the pivot pins on both the articulating links and main jaw articulating link. Thats why the single use should be the ONLY one used on the SPORT Platform!!
No clip company would purchase TMD or any other Robotic platform, not good for business. These clips are very lucrative and a clip company would want them on as many platforms as possible. Same goes for J&J.
The logical choice to purchase TMD is Karl Storz and can include a JV from the Hoya Corporation (Japan).
The end effectors on SPORT are the Microline (Hoya Corporation) type that screw on and off and can be purchased either as single use or reusable. They will have to develop an applier jaw for the Hem-O-Lok clips. Intuitive surgical already uses these clips and can be purchased for $99.00 each, model 420230.
TMD short interest 495,726 as at Feb 14, down -466,545 from Jan 31!
Karl Storz Endoscopy Inc. is a private company with annual sales in excess of $2 billion per year. I don't know their cash situation but one smart option for them would be to enter into a business combination with TMD. They could become one big public company and the owner could still probably retain 51% of the outstanding shares of TMD. Accretive structures are available, just don't count on a Bay streeter to come up with them!!
Ready for a not too wild prediction? Put the Karl Storz name on the SPORT Platform and they will surpass INTUITIVE SURGICAL INC market share in no time!!
I still say that Karl Storz Endoscopy inc. is by far the most logical business fit for full integration of the SPORT Platform. Their timing could not be better right now to JV a robotics Platform if they want to maintain world dominance. I'm still scratching my head on WHY they have not made a move yet. The other platforms would take them off course as they specialize in segments that Storz does not.
TMD consolidated 30:1 a couple of months ago, so you have to divide the warrants by the same ratio. Always work in percentages, never dollar amounts, to reflect your returns.
At glg20: I don't believe that a buyout of TMD will happen under the warrant price based on industry comps in U.S. dollars. Too many manual endoscopy manufacturers out there without a Platform. If so, a competing bid(s), especially of the hostile nature with speculation and momentum alone will have things all over the place. Warrants feed on volatility and momentum of the underlying shares with nano floats.
At BigT82: It all depends on WHO is holding the $3,20 warrants, long retail or strategic? We don't know, but my money is on strategic.
I agree that there were previous raises that were not listed and maybe they had the same intent, but the timing to execute was not without all ducks in a row. Maybe too many shares outstanding to control a move which explains the recent share consolidation and U.S listing.
We are at a stage in development that is much clearer defined to execute this type of strategic funding.
BigT82 wrote: "And finally, when demand for these extremely undervalued shares finally exceeds supply, we will get our move much, much higher. That won’t be long, IMO!"
THATS WHY I HOLD THE WARRANTS!!
So one can one assume that if we trade the same range, we too can expect to clear a 50% profit during their rinse & repeat cycle? As insurance, one can always hold some warrants for any surprise significant breakout on news, JV or buyout.
So the trading range for this rinse & repeat internal funding cycle should be $3,20 to $4,65 u.s. or $4.16 to $6,20 cdn.
I also knew that something was up when they decided to NOT have these warrants trade on the open market like every other previous a-z series and these were excerisable in U.S. funds which the company uses as a currency standard for their financials and R&D.
This type of ingenious strategic financing proposal had to include management coordination for it to work. So you can call off any short cover rally going forward!